We demonstrate that the inhibition of BRD2 deposition on ECM gene promoters by RELA K310R mutation, knockdown or using BET-BD2-specific inhibitors led to loss of ECM gene expression, MES transition and invasion of GBM cells, ultimately resulting in decreased macrophage infiltration in in vivo GBM models. Here, BRD2 is linked to glioblastoma.